8-13-3　ⓔ文献

  1. Aoyama N, Izumi T, et al: Japanese Investigators of Fulminant Myocarditis: National survey of fulminant myocarditis in Japan: therapeutic guidelines and long–term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis (special report from a scientific committee). Circ J, 2002; 66: 133–144.

  2. Cooper LT Jr, ElAmm C: Giant cell myocarditis. Diagnosis and treatment. Herz, 2012; 37: 632–636.

  3. Fung G, Luo H, et al. Myocarditis. Circ Res, 2016; 118: 496–514.

  4. Global Burden of Disease Study 2013 Risk Factors Collaborators: Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: A systematic analysis for the global burden of disease study 2013. Lancet, 2015; 386: 743–800.

  5. Vos T, Flaxman AD, et al: Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 2012; 380: 2163–2196.

  6. Chandra N, Bastiaenen R, et al. Sudden cardiac death in young athletes: practical challenges and diagnostic dilemmas. J Am Coll Cardiol, 2013; 61: 1027–1040.

  7. Fairweather D, Cooper LT Jr, et al: Sex and gender differences in myocarditis and dilated cardiomyopathy. Curr Probl Cardiol, 2013; 38: 7–46.

  8. Al-Biltagi M, Issa M, et al: Circulating cardiac troponins levels and cardiac dysfunction in children with acute and fulminant viral myocarditis. Acta Paediatr, 2010; 99: 1510–1516.

  9. Mlczoch E, Darbandi–Mesri F, et al: NT–pro BNP in acute childhood myocarditis. J Pediatr, 2012; 160: 178–179.

  10. McFalls EO, van Suylen RJ: Myocarditis as a cause of primary right ventricular failure. Chest, 1993; 103: 1607–1608.

  11. Pan JA, Lee YJ, et al: Diagnostic Performance of Extracellular Volume, Native T1, and T2 Mapping Versus Lake Louise Criteria by Cardiac Magnetic Resonance for Detection of Acute Myocarditis: A Meta–Analysis. Circ Cardiovasc Imaging, 2018, 11: e007598.

  12. Chen W, Jeudy J: Assessment of Myocarditis: Cardiac MR, PET/CT, or PET/MR?. Curr Cardiol Rep, 2019; 21: 76.

  13. McCarthy RE 3rd, Boehmer JP, et al: Long–term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med, 2000; 342: 690–695.

  14. Cooper LT Jr, Berry GJ, et al: Idiopathic giant–cell myocarditis: natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med, 1997; 336: 1860–1866.

  15. Youn JC, Shim HS, et al: Detailed pathologic evaluation on endomyocardial biopsy provides long–term prognostic information in patients with acute myocarditis. Cardiovasc, Pathol, 2014; 23: 139–144.

  16. Kyto V, Sipila J, et al: Rate and patient features associated with recurrence of acute myocarditis. Eur J Intern Med, 2014, 25: 946–950.